Activation of pp60c-src protein kinase activity in human colon carcinoma.
about
The SRC-associated protein CUB Domain-Containing Protein-1 regulates adhesion and motilityRibosomal protein genes are overexpressed in colorectal cancer: isolation of a cDNA clone encoding the human S3 ribosomal proteinActivation of the pp60c-src protein kinase is an early event in colonic carcinogenesisIncrease in activity and level of pp60c-src in progressive stages of human colorectal cancerpp60c-src activation in human colon carcinomaFaecal tumour M2 pyruvate kinase: a new, sensitive screening tool for colorectal cancerSrc kinase becomes preferentially associated with the VEGFR, KDR/Flk-1, following VEGF stimulation of vascular endothelial cells.The molecular rationale of Src inhibition in colorectal carcinomasDasatinib sensitizes KRAS mutant colorectal tumors to cetuximabThe hunting of the SrcRegulation of SRC family kinases in human cancersGlobal phosphotyrosine proteomics identifies PKCĪ“ as a marker of responsiveness to Src inhibition in colorectal cancerThe intrinsic ability of AFAP-110 to alter actin filament integrity is linked with its ability to also activate cellular tyrosine kinases.Genetic evidence for a role for Src family kinases in TNF family receptor signaling and cell survival.Bacterial expression of an active tyrosine kinase from a protein A/truncated c-src fusion protein.Identification of the SRC pyrimidine-binding protein (SPy) as hnRNP K: implications in the regulation of SRC1A transcriptionProstate apoptosis response protein 4 sensitizes human colon cancer cells to chemotherapeutic 5-FU through mediation of an NF kappaB and microRNA network.Phase I study of dasatinib in combination with capecitabine, oxaliplatin and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancerSelected glimpses into the activation and function of Src kinase.Activation of Src kinase in primary colorectal carcinoma: an indicator of poor clinical prognosis.Elevated c-Src tyrosine kinase activity in premalignant epithelia of ulcerative colitis.Down-regulation of drs mRNA in colorectal neoplasms.Breast cancer patients' clinical outcome measures are associated with Src kinase family member expression.c-Src-mediated phosphorylation of NoxA1 and Tks4 induces the reactive oxygen species (ROS)-dependent formation of functional invadopodia in human colon cancer cells.c-Src protein expression is increased in human breast cancer. An immunohistochemical and biochemical analysis.Expression of the ErbA-beta class of thyroid hormone receptors is selectively lost in human colon carcinoma.The tyrosine phosphatase PTPRO sensitizes colon cancer cells to anti-EGFR therapy through activation of SRC-mediated EGFR signalingSrc regulates the activity of the ING1 tumor suppressor.Aptameric inhibition of p210bcr-abl tyrosine kinase autophosphorylation by oligodeoxynucleotides of defined sequence and backbone structureThe SRC family of protein tyrosine kinases: a new and promising target for colorectal cancer therapy.Functional development of Src tyrosine kinases during evolution from a unicellular ancestor to multicellular animals.Drosophila C-terminal Src kinase negatively regulates organ growth and cell proliferation through inhibition of the Src, Jun N-terminal kinase, and STAT pathways.Differential pp60c-src activity in well and poorly differentiated human colon carcinomas and cell lines.Csk-Induced Phosphorylation of Src at Tyrosine 530 is Essential for H2O2-Mediated Suppression of ERK1/2 in Human Umbilical Vein Endothelial Cells.The road to Src.Nuclear expression of Lyn, a Src family kinase member, is associated with poor prognosis in renal cancer patients.High sensitivity isoelectric focusing to establish a signaling biomarker for the diagnosis of human colorectal cancer.Syndecan-1 alterations during the tumorigenic progression of human colonic Caco-2 cells induced by human Ha-ras or polyoma middle T oncogenes.Tyrosine kinases in disease: overview of kinase inhibitors as therapeutic agents and current drugs in clinical trials.Expression and prognostic significance of Src family members in renal clear cell carcinoma.
P2860
Q24310538-B28C992E-C10B-4657-829E-3782491CC5D5Q24320003-5CD83BD0-9C0B-44AA-96DF-85CD828CC684Q24559903-96ED68F2-AF2C-432A-BF06-32EEEC589D43Q24618378-FB404F75-3324-4E53-B2CE-179F331B6AF7Q24623701-1E5FDD02-BEA1-4F29-A2DD-23B5E60C81A1Q24645339-C51A927A-F655-44BD-994B-85A6022940E5Q24796859-E20F0364-F46F-4894-AD0C-182248361D1DQ26853018-E2F9C853-EAE3-497D-917D-51812E791EE0Q27851586-C4E2BDFE-260C-4B22-BFB3-DF2D695E364EQ28199081-C555B15C-8A04-49EB-87C2-E86C641986ACQ28243770-E9B30262-0EA2-4825-B218-4F06BA22DB2EQ28535249-7E34B67D-790A-4AB2-894A-15AC967AB7D4Q30167844-B51AFA17-ECCB-4EFA-8468-16386A0B0980Q30168513-33C9EB78-67DD-479D-88BA-97902760C489Q30194912-756793F7-6E2F-4E1A-9E09-DB0E2D636986Q30887759-873D9469-C554-4F8E-800D-C14F7497C9B5Q33907135-847708BC-46B0-4B4C-8010-776566D41EA9Q33940893-6BA4396A-EE6B-414D-BF85-608D9357CCADQ34103644-2D2C15E2-FD15-4D63-877C-85A99AF45A2DQ34119101-6354CE1E-089E-4001-934C-756093F2D5BEQ34124381-86022F74-2061-449B-A082-67A1C38D09CFQ34192982-90ABE876-5303-49DD-A324-98E680C2BE96Q34253693-9A26FD66-3EC5-4A9F-AB0A-66FE1D13FDABQ34361024-EC20DFDC-2F16-4FCA-B689-CF8E573CD4A9Q34414942-8F11AC85-E3D3-4F2A-8FDB-6318AEC6B5F1Q34579987-3E693241-AC9E-4966-8177-530ED5D7F8AAQ34654408-5D2A5660-FCDD-48A3-9430-86D67A3F2851Q34667873-995EC325-B95B-4368-9F6B-F3D6726CB85BQ34841821-24FF5AC8-7C19-4AB3-B2CE-FCBC02057F49Q34966503-E7D76BF3-6C28-4291-8A16-2A1368819DA5Q35033161-9E8199F6-E882-443E-8DA2-2F1276353F81Q35664007-35E16D22-3B9A-466C-88B7-1101F0022411Q35821542-5F6FC494-D248-4A8A-803C-27E8D78039A0Q35909518-0EA63A2A-815A-4835-A0A4-59D2C8C86A8AQ35920886-48763069-E849-40F7-8B70-28C440FCC048Q35960176-8595008A-8C9F-4484-A306-B5C117C36939Q36113663-0857E2AB-71EB-493A-B02C-9EDBA3F1D46DQ36135770-659A44DF-AE30-4D95-B6B9-80E956583073Q36181201-DB320257-9C1B-4702-87E8-E730FDB4E5AAQ36186331-8DABBF1E-D0FA-440C-858B-CAB08BD2F00A
P2860
Activation of pp60c-src protein kinase activity in human colon carcinoma.
description
1987 nĆ® lÅ«n-bĆ»n
@nan
1987 Õ©ÕøÖÕ”ÕÆÕ”Õ¶Õ« Ō±ÕŗÖÕ«Õ¬Õ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕøÖÕ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ ÕµÖ
Õ¤ÕøÖÕ”Õ®
@hyw
1987 Õ©Õ¾Õ”ÕÆÕ”Õ¶Õ« Õ”ÕŗÖÕ«Õ¬Õ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕ¾Õ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ Õ°ÕøÕ¤Õ¾Õ”Õ®
@hy
1987幓ć®č«ę
@ja
1987幓å¦ęÆęē«
@wuu
1987幓å¦ęÆęē«
@zh-cn
1987幓å¦ęÆęē«
@zh-hans
1987幓å¦ęÆęē«
@zh-my
1987幓å¦ęÆęē«
@zh-sg
1987幓åøč”ęē«
@yue
name
Activation of pp60c-src protein kinase activity in human colon carcinoma.
@ast
Activation of pp60c-src protein kinase activity in human colon carcinoma.
@en
Activation of pp60c-src protein kinase activity in human colon carcinoma.
@nl
type
label
Activation of pp60c-src protein kinase activity in human colon carcinoma.
@ast
Activation of pp60c-src protein kinase activity in human colon carcinoma.
@en
Activation of pp60c-src protein kinase activity in human colon carcinoma.
@nl
prefLabel
Activation of pp60c-src protein kinase activity in human colon carcinoma.
@ast
Activation of pp60c-src protein kinase activity in human colon carcinoma.
@en
Activation of pp60c-src protein kinase activity in human colon carcinoma.
@nl
P2093
P2860
P356
P1476
Activation of pp60c-src protein kinase activity in human colon carcinoma.
@en
P2093
P2860
P304
P356
10.1073/PNAS.84.8.2251
P407
P577
1987-04-01T00:00:00Z